Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension

European Respiratory Journal

Volumn 28, Issue 4, 2006, Pages 799-807

  Tamby, M C ^a   Humbert, M ^d   Gullpain, P ^a   Servettaz, A ^a   Dupin, N ^b   Christner, J J ^a   Simonneau, G ^d   Fermanian, J ^a   Weill, B ^a   Guillevln, L ^b   Mouthon, Luc ^a,b,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c Assistance Publique Hôpitaux de Paris ^*  (France)

^d HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

Anti fibroblast antibodies; Pulmonary arterial hypertension; Systemic sclerosis

Indexed keywords

ANTICOAGULANT AGENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; PROSTACYCLIN;

ADULT; ANTIBODY DETECTION; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; HEART CATHETERIZATION; HEP 2 CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SCLERODERMA; SYSTEMIC SCLEROSIS; BLOOD; CELL LINE; IMMUNOLOGY; MIDDLE AGED;

ADULT; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLASTS; HUMANS; HYPERTENSION, PULMONARY; IMMUNOBLOTTING; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC;

EID: 33845510782     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.06.00152705     Document Type: Article

References (25)

1. Rubin Q. Primary pulmonary hypertension. N Engl J Med 1997;336:111-117.
2. Barst RJ, McGoon M, Torbicki A, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43: Suppl. 12, 40S-47S.
3. Humbert M, Morrell NW, Archer SL, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43: Suppl. 12, 13S-24S.
4. Simonneau G, Galie N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004; 43: Suppl. 12, 5S-12S.
5. Sitbon O, Gressin V, Speich R, et al. Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension. Am J Respir Crit Care Med 2004; 170: 1212-1217.
6. Hachulla E, Gressin V, Guillevin L, et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 2005; 52: 3792-3800.
7. Stenmark KR, Gerasimovskaya E, Nemenoff RA, Das M. Hypoxic activation of adventitial fibroblasts: role in vascular remodeling. Chest 2002; 122: Suppl. 6, 326S-334S.
8. Tamby MC, Chanseaud Y, Humbert M, et al. Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension. Thorax 2005; 60: 765-772.
9. Chizzolini C, Raschi E, Rezzonico R, et al. Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis. Arthritis Rheum 2002; 46: 1602-1613.
10. LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001; 28: 1573-1576.
11. Masi AT, Rodnan GP, Medsger TA, et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthr Rheum 1980; 23: 581-590.
12. Moloney M, McDonnell L, O'Shea H. Atomic force microscopy of BHK-21 cells: an investigation of cell fixation techniques. Ultramicroscopy 2004; 100: 153-161.
13. Garcia de la Pena-Lefebvre P, Chanseaud Y, Tamby MC, et al. IgG reactivity with a 100-kDa tissue and endothelial cell antigen identified as topoisomerase 1 distinguishes between limited and diffuse systemic sclerosis patients. Clin Immunol 2004; 111: 241-251.
14. Chanseaud Y, Tamby MC, Guilpain P, et al. Analysis of autoantibody repertoires in small- and medium-sized vessels vasculitides. Evidence for specific perturbations in polyarteritis nodosa, microscopic polyangiitis, Churg-Strauss syndrome and Wegener's granulomatosis. J Autoimmun 2005; 24: 169-179.
15. Harman HH. Modern Factor Analysis. 2nd Edn. Chicago, The University Of Chicago Press, 1967.
16. Mouthon L, Guillevin L, Humbert M. Pulmonary arterial hypertension: an autoimmune disease? Eur Respir J 2005; 26:986-988.
17. Henault J, Tremblay M, Clement I, Raymond Y, Senecal JL. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis. Arthritis Rheum 2004; 50: 3265-3274.
18. Eddahibi S, Morrell N, d'Ortho MP, Naeije R, Adnot S. Pathobiology of pulmonary arterial hypertension. Eur Respir J 2002; 20: 1559-1572.
19. Yeager ME, Halley GR, Golpon HA, Voelkel NF, Tuder RM. Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension. Circ Res 2001; 88: 2-11.
20. Morse J, Barst R, Horn E, Cuervo N, Deng Z, Knowles J. Pulmonary hypertension in scleroderma spectrum of disease: lack of bone morphogenetic protein receptor 2 mutations. J Rheumatol 2002; 29: 2379-2381.
21. Nicolls MR, Taraseviciene-Stewart L, Rai PR, Badesch DB, Voelkel NF. Autoimmunity and pulmonary hypertension: a perspective. Eur Respir J 2005; 26: 1110-1118.
22. Cool CD, Kennedy D, Voelkel NF, Tuder RM. Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma, and human immunodeficiency virus infection. Hum Pathol 1997; 28: 434-442.
23. Okawa-Takatsuji M, Aotsuka S, Fujinami M, Uwatoko S, Kinoshita M, Sumiya M. Up-regulation of intercellular adhesion molecule-1 (ICAM-1), endothelial leucocyte adhesion molecule-1 (ELAM-1) and class II MHC molecules on pulmonary artery endothelial cells by antibodies against U1-ribonucleoprotein. Clin Exp Immunol 1999; 116:174-180.
24. Isern RA, Yaneva M, Weiner E, et al. Autoantibodies in patients with primary pulmonary hypertension: association with anti-Ku. Am J Med 1992; 93: 307-312.
25. Chu JW, Kao PN, Faul JL, Doyle RL. High prevalence of autoinumme thyroid disease in pulmonary arterial hypertension. Chest 2002; 122: 1668-1673.